1. Home
  2. CNDT vs OABI Comparison

CNDT vs OABI Comparison

Compare CNDT & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Conduent Incorporated

CNDT

Conduent Incorporated

HOLD

Current Price

$1.71

Market Cap

232.4M

ML Signal

HOLD

Logo OmniAb Inc.

OABI

OmniAb Inc.

HOLD

Current Price

$1.45

Market Cap

237.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNDT
OABI
Founded
2016
2012
Country
United States
United States
Employees
51000
89
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
232.4M
237.4M
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
CNDT
OABI
Price
$1.71
$1.45
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$4.50
AVG Volume (30 Days)
1.2M
521.0K
Earning Date
04-29-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,042,000,000.00
N/A
Revenue This Year
$2.01
$52.42
Revenue Next Year
$4.06
$64.69
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.15
$1.22
52 Week High
$2.98
$2.22

Technical Indicators

Market Signals
Indicator
CNDT
OABI
Relative Strength Index (RSI) 66.15 39.91
Support Level $1.16 $1.32
Resistance Level $2.10 $1.70
Average True Range (ATR) 0.10 0.09
MACD 0.03 0.01
Stochastic Oscillator 73.20 11.36

Price Performance

Historical Comparison
CNDT
OABI

About CNDT Conduent Incorporated

Conduent Inc acts as a provider of business process services with expertise in transaction-intensive processing, analytics, and automation. The company provides industry-focused service offerings in growth markets such as Healthcare and Transportation as well as provides multi-industry services such as transaction processing, customer care, and payment services. It operates through three segments namely Commercial Industries which is the key revenue-driving segment, Government Services, and Transportation. The group operates its business in the United States, Europe, and Other areas of which the majority of revenue is generated in the United States.

About OABI OmniAb Inc.

OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.

Share on Social Networks: